[Retinopathy and perinatal outcome in diabetic pregnancy]. 1995

H Sameshima, and M Kai, and S Kajiya, and M Kamitomo, and Y Matsuda, and K Kuraya, and M Hatae, and H Uchida, and S Fukushima, and T Ikenoue
Department of Obstetrics and Gynecology, Kagoshima City Hospital.

Sixty patients with diabetes mellitus (DM) antedated pregnancy were enrolled; seven had proliferative retinopathy, 13 had simple retinopathy, and 40 were intact. Diet and/or insulin was prescribed to adjust their glucose control at fasting to < 100 mg/dl, as well as at 2 hours postprandial to < 120 mg/dl. Glycohemoglobin (Hemoglobin A1c) levels ranged between 5.4% and 6.4% in the third trimester in three groups. Incidences of pregnancy complications (toxemia, hydramnios, urinary tract infection and cesarean section) and neonatal complications (low Apgar score, hypoglycemia, jaundice, polycythemia, respiratory distress syndrome and anomaly) did not differ significantly with the grade of retinopathy. Compared with the intact group, the duration of DM was significantly longer in the retinopathy groups and the incidence of fetal distress was significantly higher in the proliferative retinopathy group. In ten of 60 patients (16.7%) the grade of retinopathy progressed during pregnancy. In four patients photocoagulation was performed for neovascularization, and proved to be effective. There was a tendency for those whose retinopathy progressed to the proliferative stage during pregnancy to have larger decreases in glycohemoglobin and for their retinopathy to worsen after delivery. With tight maternal glucose control and intensive fetal surveillance, we obtained good perinatal outcome in pregnancies with diabetic retinopathy, as compared to diabetic pregnancy without diabetic microangiopathy. Careful and frequent monitoring of retinal changes should be required during pregnancy and the postpartum period.

UI MeSH Term Description Entries
D007231 Infant, Newborn An infant during the first 28 days after birth. Neonate,Newborns,Infants, Newborn,Neonates,Newborn,Newborn Infant,Newborn Infants
D008028 Light Coagulation The coagulation of tissue by an intense beam of light, including laser (LASER COAGULATION). In the eye it is used in the treatment of retinal detachments, retinal holes, aneurysms, hemorrhages, and malignant and benign neoplasms. (Dictionary of Visual Science, 3d ed) Photocoagulation,Coagulation, Light,Coagulations, Light,Light Coagulations,Photocoagulations
D008991 Monitoring, Physiologic The continuous measurement of physiological processes, blood pressure, heart rate, renal output, reflexes, respiration, etc., in a patient or experimental animal; includes pharmacologic monitoring, the measurement of administered drugs or their metabolites in the blood, tissues, or urine. Patient Monitoring,Monitoring, Physiological,Physiologic Monitoring,Monitoring, Patient,Physiological Monitoring
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D011254 Pregnancy in Diabetics The state of PREGNANCY in women with DIABETES MELLITUS. This does not include either symptomatic diabetes or GLUCOSE INTOLERANCE induced by pregnancy (DIABETES, GESTATIONAL) which resolves at the end of pregnancy. Pregnancy in Diabetes,Pregnancy in Diabete,Pregnancy in Diabetic
D011256 Pregnancy Outcome Results of conception and ensuing pregnancy, including LIVE BIRTH; STILLBIRTH; or SPONTANEOUS ABORTION. The outcome may follow natural or artificial insemination or any of the various ASSISTED REPRODUCTIVE TECHNIQUES, such as EMBRYO TRANSFER or FERTILIZATION IN VITRO. Outcome, Pregnancy,Outcomes, Pregnancy,Pregnancy Outcomes
D003930 Diabetic Retinopathy Disease of the RETINA as a complication of DIABETES MELLITUS. It is characterized by the progressive microvascular complications, such as ANEURYSM, interretinal EDEMA, and intraocular PATHOLOGIC NEOVASCULARIZATION. Diabetic Retinopathies,Retinopathies, Diabetic,Retinopathy, Diabetic
D005260 Female Females
D006442 Glycated Hemoglobin Products of non-enzymatic reactions between GLUCOSE and HEMOGLOBIN (occurring as a minor fraction of the hemoglobin of ERYTHROCYTES.) It generally refers to glycated HEMOGLOBIN A. Hemoglobin A1c (Hb A1c) is hemoglobin A with GLYCATION on a terminal VALINE of the beta chain. Glycated hemoglobin A is used as an index of the average blood sugar level over a lifetime of erythrocytes. Fructated Hemoglobins,Glycohemoglobin,Glycohemoglobin A,Glycohemoglobins,Glycosylated Hemoglobin A,Hb A1c,HbA1,Hemoglobin A(1),Hemoglobin A, Glycosylated,Glycated Hemoglobin A,Glycated Hemoglobin A1c,Glycated Hemoglobins,Glycosylated Hemoglobin A1c,Hb A1,Hb A1a+b,Hb A1a-1,Hb A1a-2,Hb A1b,Hemoglobin, Glycated A1a-2,Hemoglobin, Glycated A1b,Hemoglobin, Glycosylated,Hemoglobin, Glycosylated A1a-1,Hemoglobin, Glycosylated A1b,A1a-1 Hemoglobin, Glycosylated,A1a-2 Hemoglobin, Glycated,A1b Hemoglobin, Glycated,A1b Hemoglobin, Glycosylated,Glycated A1a-2 Hemoglobin,Glycated A1b Hemoglobin,Glycosylated A1a-1 Hemoglobin,Glycosylated A1b Hemoglobin,Glycosylated Hemoglobin,Hemoglobin A, Glycated,Hemoglobin A1c, Glycated,Hemoglobin A1c, Glycosylated,Hemoglobin, Glycated,Hemoglobin, Glycated A1a 2,Hemoglobin, Glycosylated A1a 1,Hemoglobins, Fructated,Hemoglobins, Glycated
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

H Sameshima, and M Kai, and S Kajiya, and M Kamitomo, and Y Matsuda, and K Kuraya, and M Hatae, and H Uchida, and S Fukushima, and T Ikenoue
August 2004, Eye (London, England),
H Sameshima, and M Kai, and S Kajiya, and M Kamitomo, and Y Matsuda, and K Kuraya, and M Hatae, and H Uchida, and S Fukushima, and T Ikenoue
February 1978, The Journal of reproductive medicine,
H Sameshima, and M Kai, and S Kajiya, and M Kamitomo, and Y Matsuda, and K Kuraya, and M Hatae, and H Uchida, and S Fukushima, and T Ikenoue
January 1988, The Journal of diabetic complications,
H Sameshima, and M Kai, and S Kajiya, and M Kamitomo, and Y Matsuda, and K Kuraya, and M Hatae, and H Uchida, and S Fukushima, and T Ikenoue
October 1980, American journal of ophthalmology,
H Sameshima, and M Kai, and S Kajiya, and M Kamitomo, and Y Matsuda, and K Kuraya, and M Hatae, and H Uchida, and S Fukushima, and T Ikenoue
January 1990, Diabete & metabolisme,
H Sameshima, and M Kai, and S Kajiya, and M Kamitomo, and Y Matsuda, and K Kuraya, and M Hatae, and H Uchida, and S Fukushima, and T Ikenoue
August 1978, Diabetologia,
H Sameshima, and M Kai, and S Kajiya, and M Kamitomo, and Y Matsuda, and K Kuraya, and M Hatae, and H Uchida, and S Fukushima, and T Ikenoue
October 1987, Bulletin des societes d'ophtalmologie de France,
H Sameshima, and M Kai, and S Kajiya, and M Kamitomo, and Y Matsuda, and K Kuraya, and M Hatae, and H Uchida, and S Fukushima, and T Ikenoue
May 1999, Journal francais d'ophtalmologie,
H Sameshima, and M Kai, and S Kajiya, and M Kamitomo, and Y Matsuda, and K Kuraya, and M Hatae, and H Uchida, and S Fukushima, and T Ikenoue
January 1995, Bulletin de la Societe belge d'ophtalmologie,
H Sameshima, and M Kai, and S Kajiya, and M Kamitomo, and Y Matsuda, and K Kuraya, and M Hatae, and H Uchida, and S Fukushima, and T Ikenoue
August 2014, International ophthalmology,
Copied contents to your clipboard!